| 1. |
Khim G, Em S, Mo S, et al. Liver abscess: diagnostic and management issues found in the low resource setting. Br Med Bull, 2019, 132(1): 45-52.
|
| 2. |
Thng CB, Tan YP, Shelat VG. Gas-forming pyogenic liver abscess: A world review. Ann Hepatobiliary Pancreat Surg, 2018, 22(1): 11-18.
|
| 3. |
Du ZQ, Zhou XC, Zhao JZ, et al. Effect of diabetes mellitus on short-term prognosis of 227 pyogenic liver abscess patients after hospitalization. BMC Infect Dis, 2020, 20(1): 145.
|
| 4. |
Ko MC, Lin WH, Martini S, et al. A cohort study of age and sex specific risk of pyogenic liver abscess incidence in patients with type 2 diabetes mellitus. Medicine (Baltimore), 2019, 98(17): e15366.
|
| 5. |
Chen J, Zhang M, Chen J, et al. Cryptogenic and non-cryptogenic liver abscess: A retrospective analysis of 178 cases revealed distinct characteristics. J Int Med Res, 2018, 46(9): 3824-3836.
|
| 6. |
Gallagher MC, Andrews MM. Postdischarge outcomes of pyogenic liver abscesses: single-center experience 2007–2012. Open Forum Infect Dis, 2017, 4(3): ofx159.
|
| 7. |
Neill L, Edwards F, Collin SM, et al. Clinical characteristics and treatment outcomes in a cohort of patients with pyogenic and amoebic liver abscess. BMC Infect Dis, 2019, 19(1): 490.
|
| 8. |
楊娜, 張化冰, 李玉秀. 《美國糖尿病學會2019年版糖尿病醫學診療標準》更新與解讀. 協和醫學雜志, 2019, 10(5): 476-480.
|
| 9. |
中國醫師協會急診醫師分會, 中國研究型醫院學會休克與膿毒癥專業委員會. 中國膿毒癥/膿毒性休克急診治療指南(2018). 中國急救醫學, 2018, 38(9): 741-756.
|
| 10. |
齊文旗, 黃椿媚, 邊帆, 等. 肝膿腫致膿毒血癥的危險因素及早期診斷. 中華急診醫學雜志, 2019, 28(11): 1383-1389.
|
| 11. |
Li W, Chen H, Wu S, et al. A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC Gastroenterol, 2018, 18(1): 144.
|
| 12. |
惠鵬, 朱鵬, 廖威, 等. BLA菌群分布與耐藥性分析的多中心回顧性研究(附897例報告). 中華消化外科雜志, 2019, 18(10): 924-933.
|
| 13. |
Yeh YT, Wang BY, Lin CW, et al. Periodontitis and dental scaling associated with pyogenic liver abscess: A population-based case-control study. J Periodontal Res, 2018, 53(5): 785-792.
|
| 14. |
Xu J, Zhou X, Zheng C. The geriatric nutritional risk index independently predicts adverse outcomes in patients with pyogenic liver abscess. BMC Geriatr, 2019, 19(1): 14.
|
| 15. |
Kim EJ, Ha KH, Kim DJ, et al. Diabetes and the risk of infection: a national cohort study. Diabetes Metab J, 2019, 43(6): 804-814.
|
| 16. |
馬海濤, 陳國宙, 王煊, 等. 2型糖尿病對細菌性肝膿腫病情影響的研究. 中華醫院感染學雜志, 2019, 29(9): 1351-1354.
|
| 17. |
Wang WJ, Tao Z, Wu HL. Etiology and clinical manifestations of bacterial liver abscess: a study of 102 cases. Medicine, 2018, 97(38): e12326.
|
| 18. |
Ruiz-Hernández JJ, Conde-Martel A, Serrano-Fuentes M, et al. Pyogenic liver abscesses due to Escherichia coli are still related to worse outcomes. Ir J Med Sci, 2020, 189(1): 155-161.
|
| 19. |
柳濤, 張莉. 《2016年英國國家衛生與臨床優化研究所非酒精性脂肪性肝病的評估和管理指南》摘譯. 臨床肝膽病雜志, 2016, 32(11): 2036-2038.
|
| 20. |
Lai SW, Lin CL, Liao KF. Population-based cohort study investigating the association between weight loss and pyogenic liver abscesses. BioMedicine, 2017, 7(4): 26.
|
| 21. |
Lai SW. Early predictors for the diagnosis of pyogenic liver abscess. Intern Emerg Med, 2019, 14(6): 1011-1012.
|
| 22. |
Hoh CH, Tan YH, Gan YH. Protective role of kupffer cells and macrophages in Klebsiella pneumoniae-induced liver abscess disease. Infect Immun, 2019, 87(9): e00369-e00319.
|
| 23. |
陳薇, 楊春鳳, 曹陽, 等. 肺炎克雷伯菌肝膿腫發病危險因素及致病菌耐藥性分析. 中華傳染病雜志, 2018, 36(10): 630-634.
|
| 24. |
Xu S, Wang Y, Chen J, et al. Application of ultrasound-guided percutaneous intrahepatic portal vein catheterization with antibiotic injection for treating unliquefied bacterial liver abscess. Hepatol Res, 2017, 47(3): E187-E192.
|
| 25. |
廖衛, 劉秉彥, 楊炳昂, 等. 介入性超聲在細菌感染性肝膿腫患者中的應用效果研究. 中華醫院感染學雜志, 2017, 27(16): 3715-3718.
|
| 26. |
Mi?ek T, Ciostek P. Percutaneous treatment of liver abscess–outcomes. Prz Gastroenterol, 2019, 14(2): 129-132.
|